In the context of cancer, increased expression of A ADAR1-p150 has been demonstrated to restrict the binding of ZBP1 and RIPK3, consequently suppressing ZBP1-mediated PANoptosis to facilitate tumor growth [68]. Here, RIPK3 is linked to neoplasm.